Literature DB >> 33085175

FRACPRED-2D-PRM: A Fraction Prediction Algorithm-Assisted 2D Liquid Chromatography-Based Parallel Reaction Monitoring-Mass Spectrometry Approach for Measuring Low-Abundance Proteins in Human Plasma.

Jian Shi1, Jingcheng Xiao2, Jiapeng Li1, Xinwen Wang1, Lucy Her2, Matthew J Sorensen3, Hao-Jie Zhu1.   

Abstract

Multidimensional fractionation-based enrichment methods improve the sensitivity of proteomic analysis for low-abundance proteins. However, a major limitation of conventional multidimensional proteomics is the extensive labor and instrument time required for analyzing many fractions obtained from the first dimension separation. Here, a fraction prediction algorithm-assisted 2D LC-based parallel reaction monitoring-mass spectrometry (FRACPRED-2D-PRM) approach for measuring low-abundance proteins in human plasma is presented. Plasma digests are separated by the first dimension high-pH RP-LC with data-dependent acquisition (DDA). The FRACPRED algorithm is then usedto predict the retention times of undetectable target peptides according to those of other abundant plasma peptides during the first dimension separation. Fractions predicted to contain target peptides are analyzed by the second dimension low-pH nano RP-LC PRM. The accuracy and robustness of fraction prediction with the FRACPRED algorithm are demonstrated by measuring two low-abundance proteins, aldolase B and carboxylesterase 1, in human plasma. The FRACPRED-2D-PRM proteomics approach demonstrates markedly improved efficiency and sensitivity over conventional 2D-LC proteomics assays. It is expected that this approach will be widely used in the study of low-abundance proteins in plasma and other complex biological samples.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  2D-LC; PRM; fraction prediction algorithm; low-abundance proteins; plasma

Year:  2020        PMID: 33085175      PMCID: PMC7744362          DOI: 10.1002/pmic.202000175

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  21 in total

1.  High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins.

Authors:  Elisa Bellei; Stefania Bergamini; Emanuela Monari; Luca Isaia Fantoni; Aurora Cuoghi; Tomris Ozben; Aldo Tomasi
Journal:  Amino Acids       Date:  2010-05-22       Impact factor: 3.520

2.  Depletion of abundant plasma proteins and limitations of plasma proteomics.

Authors:  Chengjian Tu; Paul A Rudnick; Misti Y Martinez; Kristin L Cheek; Stephen E Stein; Robbert J C Slebos; Daniel C Liebler
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

3.  The spectrum of aldolase B (ALDOB) mutations and the prevalence of hereditary fructose intolerance in Central Europe.

Authors:  René Santer; Johannes Rischewski; Michaela von Weihe; Marko Niederhaus; Sonja Schneppenheim; Kurt Baerlocher; Alfried Kohlschütter; Ania Muntau; Hans-Georg Posselt; Beat Steinmann; Reinhard Schneppenheim
Journal:  Hum Mutat       Date:  2005-06       Impact factor: 4.878

4.  Plasma Proteome Profiling to Assess Human Health and Disease.

Authors:  Philipp E Geyer; Nils A Kulak; Garwin Pichler; Lesca M Holdt; Daniel Teupser; Matthias Mann
Journal:  Cell Syst       Date:  2016-03-23       Impact factor: 10.304

5.  Comparison of protein expression between human livers and the hepatic cell lines HepG2, Hep3B, and Huh7 using SWATH and MRM-HR proteomics: Focusing on drug-metabolizing enzymes.

Authors:  Jian Shi; Xinwen Wang; Lingyun Lyu; Hui Jiang; Hao-Jie Zhu
Journal:  Drug Metab Pharmacokinet       Date:  2018-03-10       Impact factor: 3.614

6.  Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic Polymorphisms.

Authors:  Jian Shi; Xinwen Wang; Rachel F Eyler; Yan Liang; Li Liu; Bruce A Mueller; Hao-Jie Zhu
Journal:  Basic Clin Pharmacol Toxicol       Date:  2016-07-21       Impact factor: 4.080

Review 7.  Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.

Authors:  Tujin Shi; Dian Su; Tao Liu; Keqi Tang; David G Camp; Wei-Jun Qian; Richard D Smith
Journal:  Proteomics       Date:  2012-04       Impact factor: 3.984

8.  Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes.

Authors:  Julie M Pratt; Deborah M Simpson; Mary K Doherty; Jenny Rivers; Simon J Gaskell; Robert J Beynon
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

9.  The ABCs of finding a good antibody: How to find a good antibody, validate it, and publish meaningful data.

Authors:  Poulomi Acharya; Anna Quinlan; Veronique Neumeister
Journal:  F1000Res       Date:  2017-06-08

10.  High-precision iRT prediction in the targeted analysis of data-independent acquisition and its impact on identification and quantitation.

Authors:  Roland Bruderer; Oliver M Bernhardt; Tejas Gandhi; Lukas Reiter
Journal:  Proteomics       Date:  2016-06-28       Impact factor: 3.984

View more
  2 in total

1.  Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof-of-Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism.

Authors:  Jian Shi; Jingcheng Xiao; Xinwen Wang; Sun Min Jung; Barry E Bleske; John S Markowitz; Kennerly S Patrick; Hao-Jie Zhu
Journal:  Clin Pharmacol Ther       Date:  2021-11-30       Impact factor: 6.903

Review 2.  Omics of endothelial cell dysfunction in sepsis.

Authors:  Jordan C Langston; Michael T Rossi; Qingliang Yang; William Ohley; Edwin Perez; Laurie E Kilpatrick; Balabhaskar Prabhakarpandian; Mohammad F Kiani
Journal:  Vasc Biol       Date:  2022-04-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.